FIELD: neurology. SUBSTANCE: when treating nervous system vascular diseases, 200 ml of physiological solution containing 4-6 mg/l ozone is intravenously administered daily for 5 days in addition to conventional therapy. EFFECT: enhanced treatment efficiency. 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING DISCIRCULATORY ENCEPHALOPATHIES | 1997 |
|
RU2163124C2 |
METHOD FOR TREATING INITIAL FORMS OF CEREBROVASCULAR PATHLOGY AT THE BACKGROUND OF ARTERIAL HYPERTENSION | 2004 |
|
RU2281747C1 |
METHOD FOR TREATING DISCIRCULATORY ENCEPHALOPATHY | 2003 |
|
RU2242989C2 |
METHOD OF TREATMENT OF ODONTOGENOUS PHLEGMONS OF MAXILLOFACIAL REGION | 1996 |
|
RU2140769C1 |
METHOD OF TREATMENT OF PATIENTS WITH VEGETAL DYSTONIA SYNDROME | 1995 |
|
RU2124356C1 |
METHOD OF TREATING ACUTE ISCHEMIC INSULT | 1998 |
|
RU2163125C2 |
METHOD FOR TREATING NERVOUS SYSTEM DISEASES | 1999 |
|
RU2178288C2 |
METHOD OF TREATING PATIENTS WITH STAGE I-II HYPERTENSIVE DISCIRCULATORY ENCEPHALOPATHY | 2009 |
|
RU2405591C1 |
METHOD OF TREATING DEGREE 1 DISCIRCULATORY ENCEPHALOPATHY COMPLICATED BY CLIMACTERIC SYNDROME | 2010 |
|
RU2429856C1 |
METHOD FOR ADJUSTING HEMOSTASIS SYSTEM PROPERTIES | 1998 |
|
RU2166949C2 |
Authors
Dates
1999-10-10—Published
1995-02-20—Filed